Arata Horii

Chemoradiotherapy with 3-weekly CDDP 80 mg/m2 for head and neck squamous cell carcinoma: 5-year survival data from a phase 2 study

Nao Takahashi, Hisayuki Ota, Yushi Ueki, 2022, Frontiers in Surgery.